Roadside Drug Testing Devices Market Size, Share, Trends, Growth 2032
Roadside Drug Testing Devices Market By Substance (Alcohol and Drugs), By Sample Type (Urine, Sweat, Saliva, and Others), By Modality (Standalone and Handheld Devices), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.50 Billion | USD 8.49 Billion | 21.28% | 2023 |
Description
How big is the Roadside Drug Testing Devices Market?
According to the report published by Zion Market Research, the global Roadside Drug Testing Devices Market size was valued at USD 1.50 Billion in 2023 and is predicted to reach USD 8.49 Billion by the end of 2032. The market is expected to grow with a CAGR of 21.28% during the forecast period.
The report analyzes the global Roadside Drug Testing Devices Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Roadside Drug Testing Devices industry.
Request Free SampleRequest Free Sample
Global Roadside Drug Testing Devices Market: Overview
Roadside drug testing is utilized to identify the presence of the drugs in humans by extracting biological samples like urine, blood, & hair and further analyzing them. The roadside drug testing devices also assist in examining the level of drugs in the blood. These devices are compact handheld testing equipment that also utilizes the breath specimens of the driver.
Global Roadside Drug Testing Devices Market: Growth Factors
The presence of stringent laws regarding the consumption of alcohol and drugs across all the regions is fuelling the growth of the global roadside drug testing devices market. Furthermore, the growing number of accidents due to driving after consuming alcohol or drugs will further escalate the need for roadside drug testing. Alcohol and drug abuse are growing at an alarming rate all across the globe, which in turn is resulting in an increasing focus of authorities on ramping up drug and alcohol testing.
However, such emerging scenarios are creating several lucrative growth opportunities in the global roadside drug testing devices market. In addition, the surging utilization of rapid oral fluid screening devices by independent laboratories to perform diagnostic procedures will also support the growth of the market. The companies involved in the roadside drug testing devices are boosting their production capabilities to manufacture innovative handheld devices.
Furthermore, the companies in the market are able to conduct improved analyses of psychomotor functioning and cognitive behavior of individuals via clinical trials due to the introduction of advanced driving simulators. The ongoing technological advancements and innovations in the field of testing devices are likely to improve accuracy by minimizing errors. Companies are building lightweight devices which are user-friendly and can collect a large number of samples. Also, they are making constant efforts to develop devices that can easily detect even the low quantity of THC analytes.
Request Free SampleRequest Free Sample
Global Roadside Drug Testing Devices Market: Segmentation
The global roadside drug testing devices market can be segmented into substance, sample type, modality, and region.
By substance, the market can be segmented into alcohol and drugs. The alcohol segment accounts for the largest share in the global roadside drug testing devices market. However, the drug segment is likely to be the fastest-growing segment during the forecast period. The drug segment can further be bifurcated into opioids, benzodiazepines, amphetamine, cocaine, tetrahydrocannabinol, and others.
By sample type, the market can be segmented into urine, sweat, saliva, and others. The others segment including the breath specimen holds the largest share in the global market.
By modality, the market can be segmented into standalone and handheld devices. The handheld devices segment holds hegemony over others due to its ease of use and portability feature.
Roadside Drug Testing Devices Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Roadside Drug Testing Devices Market |
| Market Size in 2023 | USD 1.50 Billion |
| Market Forecast in 2032 | USD 8.49 Billion |
| Growth Rate | CAGR of 21.28% |
| Number of Pages | 205 |
| Key Companies Covered | MangalIndia.com, Inc., Lifeloc Technologies, Inc., Intoximeters, EnviteC, Drägerwerk AG & Co. KGaA, Cannabix Technologies Inc., BACtrack, Alcohol Countermeasure Systems Corp, Akers Biosciences, Inc., AK GlobalTech Corporation., Securetec, and UriTox, LLC, Pacific Data Systems Pty Ltd, MAVAND Solutions GmbH, CareHealth America, Oranoxis Inc., and Abbott Laboratories |
| Segments Covered | By substance, By sample type, By modality and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Roadside Drug Testing Devices Market: Regional analysis
North America accounts for the largest share in the global roadside drug testing devices market due to the growing number of drug and alcohol consumers in the region. Also, the alarming cases of accidents owing to the drunk drivers will further promulgate the growth of the regional market. The ongoing technological advancements in the field of roadside drug testing devices in the region to launch compact and advanced testing kits are likely to further propel the growth in the forthcoming years.
Europe accounts for the second-largest share in the global roadside drug testing devices market due to the high consumption of drugs and alcohol among the population in the region.
However, Asia Pacific is expected to be the fastest-growing region in the forthcoming years due to the growing disposable income of the people in the region.
Roadside Drug Testing Devices Market: Competitive Analysis
The global roadside drug testing devices market is led by players like:
- MangalIndia.com, Inc
- Lifeloc Technologies, Inc
- Intoximeters
- EnviteC
- Drägerwerk AG & Co. KGaA
- Cannabix Technologies Inc
- BACtrack
- Alcohol Countermeasure Systems Corp
- Akers Biosciences, Inc
- AK GlobalTech Corporation
- Securetec
- UriTox, LLC
- Pacific Data Systems Pty Ltd
- MAVAND Solutions GmbH
- CareHealth America
- Oranoxis Inc
- Abbott Laboratories
The global roadside drug testing devices market is segmented as follows:
By Substance
- Alcohol
- Drugs
By Sample Type
- Urine
- Sweat
- Saliva
- Others
By Modality
- Standalone
- Handheld Devices
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Table Of Content
FrequentlyAsked Questions
Roadside drug testing devices detect drug use in drivers. They support law enforcement and road safety checks.
The global Roadside Drug Testing Devices market is expected to be driven by the Growth supported by stricter road safety enforcement, rising DUI/DUID concerns, and demand for quick on-site screening. Technological improvements and government initiatives increase deployment.
According to study, the global Roadside Drug Testing Devices market size was worth around USD 1.50 Billion in 2023 and is predicted to grow to around USD 8.49 Billion By 2032.
The global Roadside Drug Testing Devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 21.28% during the forecast period from 2024-2032.
The global Roadside Drug Testing Devices industry is projected to be challenged by Challenges include accuracy and legal defensibility requirements, privacy concerns, and variability in regulations across jurisdictions.
The Opportunities include stricter DUI enforcement, workplace and roadside safety programs, adoption of rapid saliva testing, and technology improvements boosting reliability will offer significant growth opportunities in the Roadside Drug Testing Devices market.
Rapid multi-panel saliva testing with improved specificity; connected devices for chain-of-custody and reporting; non-invasive sampling and tamper-resistant cartridges are the emerging trends and innovations impacting the Roadside Drug Testing Devices market.
The global Roadside Drug Testing Devices market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Roadside Drug Testing Devices market are; MangalIndia.com, Inc., Lifeloc Technologies, Inc., Intoximeters, EnviteC, Drägerwerk AG & Co. KGaA, Cannabix Technologies Inc., BACtrack, Alcohol Countermeasure Systems Corp, Akers Biosciences, Inc., AK GlobalTech Corporation., Securetec, and UriTox, LLC, Pacific Data Systems Pty Ltd, MAVAND Solutions GmbH, CareHealth America, Oranoxis Inc., and Abbott Laboratories and others.
The report explores crucial aspects of the Roadside Drug Testing Devices market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
